Evidence map›Paper›PMID 38935243›Full record

ReviewCurrent pain and headache reports2024

Immune Competence and Pain: A Narrative Review.

Stefano Coaccioli, Piercarlo Sarzi-Puttini, Diego M M Fornasari, Vittorio Schweiger, Panagiotis Zis, Omar Viswanath, Giustino Varrassi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pain and headache reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Sodium channels NaNeurobiology of pain (Cambridge, Mass.)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stefano CoaccioliPresident European League Against Pain, Zurich, Switzerland. stefano.coaccioli@gmail.com.ORCID http://orcid.org/0000-0001-9972-1366
Piercarlo Sarzi-PuttiniDept. of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.ORCID http://orcid.org/0000-0002-8673-5133
Diego M M FornasariDept. of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.ORCID http://orcid.org/0000-0002-9668-3103
Vittorio SchweigerDept. of Anesthesia, Intensive Care and Pain Therapy, Verona University Hospital, Verona, Italy.ORCID http://orcid.org/0000-0001-9833-4997
Panagiotis ZisMedical School University of Cyprus, Nicosia, Cyprus.
Omar ViswanathClinical Professor of Anesthesiology, Creighton University School of Medicine, Phoenix, AZ, USA.
Giustino VarrassiPresident, Paolo Procacci Foundation, Rome, Italy.ORCID http://orcid.org/0000-0002-3822-2923

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis review aims to summarize current knowledge on the pathophysiology of pain and the role of neuro-immune crosstalk in the development of acute and chronic pain (CP). Specifically, the review focuses on the role of immune cells involved in the innate and acquired immune response, emphasizing their bidirectional interactions with the nervous systems and discussing the implications of this crosstalk on acute and CP management. RECENT

findingsIn the last two decades, multiple studies have uncovered the important role of the immune system in initiating, maintaining, and resolving pain stimuli. Furthermore, researchers discovered that the immune system interacts tightly with the nervous system, creating a bidirectional crosstalk in which immune cells influence the response of peripheral and central nerve fibers while neurotransmitters and neuropeptides released by nociceptors directly and indirectly modulate the immune response. The neuro-immune crosstalk in acute and CP is a complex and not fully understood process that comprise the interactions of multiple diverse molecules, bidirectional interferences, and numerous redundant processes. Despite the complexity, important steps have been taken in recent years toward explaining the specific roles of each immune cell type and molecule in the initiation, maintenance and resolution of pain. These findings may set the basis for innovative therapeutic options that target the immune system, overcoming the limitations of current treatments in providing pain relief and the disadvantages associated with opioid therapy.

Indexed as

Chronic PainAnimalsHumansNeuroimmunomodulationPainPain ManagementAcute painChronic painImmune cellsImmune systemNervous systemNeuro-immune crosstalk

Identifiers

PMID38935243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.